Navigation Links
TRIANNI Signs Licensing Agreement for Transgenic Mouse Platform Use with Janssen
Date:2/15/2017

SAN FRANCISCO, Feb. 15, 2017 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") announced today that it has entered into a license agreement with Janssen Biotech, Inc. (Janssen) for use of The Trianni Mouse, a best-in-class monoclonal antibody discovery platform.

Distinguished by novel chimeric gene segment design, the Trianni platform provides Janssen with access to a complete human antibody repertoire that has been optimized for the rapid isolation of fully-human therapeutics. "We are very pleased with the Janssen decision to adopt the Trianni Mouse," commented Dr. Matthias Wabl, Ph.D., Chairman and CEO of TRIANNI. "With its highly differentiated features, most notably a full human antibody repertoire assembled from gene segments that are under mouse regulatory control, we are confident the platform will prove extremely productive for Janssen."

About Trianni, Inc.
TRIANNI is a privately held organization, formed in 2010 with a mission to use recent advances in DNA synthesis and genomic modification technology for the development of an optimized therapeutic antibody discovery platform, The Trianni Mouse. The company is headquartered in San Francisco, CA. Additional information about TRIANNI is available through its corporate website, www.trianni.com

Contact
Mandy Boyd
Director of Marketing
1.415.231.0256 [o]
1.866.674.9314
mandy.boyd@trianni.com 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trianni-signs-licensing-agreement-for-transgenic-mouse-platform-use-with-janssen-300407881.html


'/>"/>
SOURCE Trianni, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. TRIANNI Announces Issuance of Russian Federation Patent
2. THC Signs Definitive Agreement to Purchase Clone Shipper
3. AGC Signs Agreement for Acquisition of Leading Biopharmaceutical CDMO, CMC Biologics
4. Fischer resigns as Neogen director
5. Dovetail Genomics Signs Japan Distribution Agreement
6. Craft Beer Pioneer, Lagunitas, Signs Up to Save $22.5M in Water, Wastewater, and Energy Costs with Cambrian Innovation’s WEPA
7. WuXi Biologics and Prima Signs MOU and Announces Strategic Development and Manufacturing Partnership
8. Oncimmune Signs Agreement with Accu Reference
9. Thought-Leading Physician, Dr. David Agus, Signs on to Advise uBiome
10. South Dakota Mines Signs Collaborative Agreement with Harvard Business School
11. Epsilon Signs New Multi-Year Agreement To Provide Global Database Marketing Services For Worldwide Biotechnology Leader Shire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... RoviSys, a ... today that it has joined the Cisco® Digital Solutions Integrator Program. As a ... hardware and software that addresses Industrial IT and Business IT in manufacturing environments. ...
(Date:2/28/2017)... ... , ... Over 8,000 recognized rare diseases afflict an estimated 350 million people ... March 7, DrugDev will gather international experts to share challenges and provide insight and ... Overcoming the Challenges of Rare Disease Clinical Trials, Date: March 7, 2017, Time: 10:00-11:00 ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen Inc ... millions-diverse immune repertoires, today announced a strategic partnership with Trianni, Inc. , ... express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody ...
(Date:2/28/2017)... and PHILADELPHIA , Feb. 28, 2017 ... held biopharmaceutical company focusing on debilitating diseases including rare ... announced that the company joins with the National Organization ... advocacy and support around the world in commemorating Rare ... unique challenges and needs of the millions of patients ...
Breaking Biology Technology:
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
(Date:2/24/2017)... Feb. 24, 2017  EyeLock LLC, a leader of iris-based ... iris biometric solution on the latest Qualcomm® Snapdragon™ ... Mobile World Congress 2017 (February 27 – ... Hall 3, Stand 3E10. The ... security platform—a combination of hardware, software and ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):